Johnson & Johnson Taiwan
Part of Johnson & Johnson
Organization
Trials
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
Phase 4, Completed, 18 people, Oct 20, 2014
Phase 3, Completed, 14 people, Feb 28, 2013
Phase 4, Terminated, 17 people, Aug 21, 2012
Phase 4, Completed, 80 people, Oct 6, 2008
Phase 4, Terminated, 8 people, Oct 6, 2008
Phase 2, Completed, 37 people, Sep 1, 2008
Phase 4, Completed, 60 people, Dec 18, 2007
Phase 4, Completed, 31 people, Sep 10, 2007
Sources: clinicaltrials.gov